Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
Chang Hyun Park, Mee Kum Kim, Eun Chul Kim, Jae Yong Kim, Tae-Im Kim, Hong Kyun Kim, Jong Suk Song, Kyung-Chul Yoon, Do Hyung Lee, Hyung Keun Lee, Tae-Young Chung, Chul Young Choi, Hyun Seung Kim
Korean J Ophthalmol. 2019;33(4):343-352.   Published online 2019 Aug 5     DOI: https://doi.org/10.3341/kjo.2018.0116
Citations to this article as recorded by Crossref logo
Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome
Mehmet Ozgur Cubuk, Ahmet Yucel Ucgul, Armagan Ozgur, Kemal Ozulken, Erdem Yuksel
International Ophthalmology.2021;[Epub]     CrossRef
Methods of drug therapy for severe dry eye disease
G. R. Semak
Proceedings of the National Academy of Sciences of Belarus, Medical series.2021; 18(1): 109.     CrossRef
The Protective Effect of an Eye Wash Solution on the Ocular Surface Damage Induced by Airborne Carbon Black Exposure
Xiangzhe Li, Boram Kang, Youngsub Eom, Hyung Keun Lee, Hyo Myung Kim, Jong Suk Song
Cornea.2020; 39(8): 1040.     CrossRef
Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
Chang Hyun Park, Hyung Keun Lee, Mee Kum Kim, Eun Chul Kim, Jae Yong Kim, Tae-im Kim, Hong Kyun Kim, Jong Suk Song, Kyung Chul Yoon, Do Hyung Lee, Tae-Young Chung, Chul Young Choi, Hyun Seung Kim
BMC Ophthalmology.2020;[Epub]     CrossRef